This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.63% per year. These returns cover a period from January 1, 1988 through December 2, 2019. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
zacks-rank: Archive
Amprius Technologies (AMPX) Reports Q3 Loss, Beats Revenue Estimates
by Zacks Equity Research
Amprius (AMPX) delivered earnings and revenue surprises of +50.00% and +25.56%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
AMPXNegative Net Change DSPNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Take-Two Interactive (TTWO) Q2 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Take-Two (TTWO) delivered earnings and revenue surprises of +60.44% and +12.93%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
TTWONegative Net Change GTNPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
10x Genomics (TXG) Reports Q3 Loss, Beats Revenue Estimates
by Zacks Equity Research
10x Genomics (TXG) delivered earnings and revenue surprises of +18.52% and +4.64%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
TXGNegative Net Change OMNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
National Health Investors (NHI) Tops Q3 FFO and Revenue Estimates
by Zacks Equity Research
National Health Investors (NHI) delivered FFO and revenue surprises of +6.45% and +8.07%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
NHINegative Net Change RMRPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Nektar Therapeutics (NKTR) Reports Q3 Loss, Beats Revenue Estimates
by Zacks Equity Research
Nektar (NKTR) delivered earnings and revenue surprises of +35.09% and +11.42%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
NKTRPositive Net Change MDWDNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Universal Display Corp. (OLED) Lags Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Universal Display (OLED) delivered earnings and revenue surprises of -22.69% and -14.09%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
OLEDNegative Net Change LPTHNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Amphastar Pharmaceuticals (AMPH) Q3 Earnings and Revenues Top Estimates
by Zacks Equity Research
Amphastar (AMPH) delivered earnings and revenue surprises of +20.78% and +3.96%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
AMPHNegative Net Change CVACNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Astrana Health, Inc. (ASTH) Misses Q3 Earnings Estimates
by Zacks Equity Research
Astrana Health, Inc. (ASTH) delivered earnings and revenue surprises of -97.87% and +0.61%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
ASTHPositive Net Change AUNAPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
JFrog Ltd. (FROG) Surpasses Q3 Earnings and Revenue Estimates
by Zacks Equity Research
JFrog (FROG) delivered earnings and revenue surprises of +37.50% and +6.63%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
FROGPositive Net Change RSKDNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Affirm Holdings (AFRM) Surpasses Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Affirm Holdings (AFRM) delivered earnings and revenue surprises of +109.09% and +5.46%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
AFRMNegative Net Change ADSKNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Nerdy Inc. (NRDY) Reports Q3 Loss, Lags Revenue Estimates
by Zacks Equity Research
Nerdy (NRDY) delivered earnings and revenue surprises of +37.50% and -5.58%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
NRDYNegative Net Change KLCNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Natera (NTRA) Reports Q3 Loss, Beats Revenue Estimates
by Zacks Equity Research
Natera (NTRA) delivered earnings and revenue surprises of -64.10% and +15.77%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
NTRANegative Net Change SGRYNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Genpact (G) Q3 Earnings and Revenues Top Estimates
by Zacks Equity Research
Genpact (G) delivered earnings and revenue surprises of +7.78% and +2.10%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
GNegative Net Change DAVAPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Mettler-Toledo (MTD) Beats Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Mettler-Toledo (MTD) delivered earnings and revenue surprises of +4.99% and +3.84%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
MTDNegative Net Change STXSNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Prothena (PRTA) Reports Q3 Loss, Lags Revenue Estimates
by Zacks Equity Research
Prothena (PRTA) delivered earnings and revenue surprises of -11.67% and -90.26%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
PRTANegative Net Change FBIOPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Protagonist Therapeutics (PTGX) Reports Q3 Loss, Lags Revenue Estimates
by Zacks Equity Research
Protagonist Therapeutics (PTGX) delivered earnings and revenue surprises of -5.08% and -52.88%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
PTGXPositive Net Change ADCTPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Drilling Tools International Corp. (DTI) Tops Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Drilling Tools International Corp. (DTI) delivered earnings and revenue surprises of +300.00% and +9.44%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
DTINegative Net Change ACDCNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Fidelity National Financial (FNF) Q3 Earnings and Revenues Top Estimates
by Zacks Equity Research
Fidelity National Financial (FNF) delivered earnings and revenue surprises of +13.99% and +13.54%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
FNFNegative Net Change BMOPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
HireQuest, Inc. (HQI) Surpasses Q3 Earnings and Revenue Estimates
by Zacks Equity Research
HireQuest (HQI) delivered earnings and revenue surprises of +71.43% and +11.42%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
HQINegative Net Change CXMNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
IREN Limited (IREN) Reports Q1 Loss, Beats Revenue Estimates
by Zacks Equity Research
IREN Limited (IREN) delivered earnings and revenue surprises of -342.86% and +8.83%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
IRENNegative Net Change INTRNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
AbCellera Biologics Inc. (ABCL) Reports Q3 Loss, Tops Revenue Estimates
by Zacks Equity Research
ABCELLERA BIOLG (ABCL) delivered earnings and revenue surprises of -11.76% and +35.31%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
ABCLNegative Net Change CLSDNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
AerSale Corporation (ASLE) Misses Q3 Earnings and Revenue Estimates
by Zacks Equity Research
AerSale (ASLE) delivered earnings and revenue surprises of -60.00% and -16.96%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
ASLENegative Net Change AVAVNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
DiamondRock Hospitality (DRH) Surpasses Q3 FFO and Revenue Estimates
by Zacks Equity Research
DiamondRock Hospitality (DRH) delivered FFO and revenue surprises of +16.00% and +0.72%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
DRHPositive Net Change GBDCNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Sweetgreen, Inc. (SG) Reports Q3 Loss, Lags Revenue Estimates
by Zacks Equity Research
Sweetgreen (SG) delivered earnings and revenue surprises of -50.00% and -4.23%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
SGNegative Net Change FATNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
The Beauty Health Company (SKIN) Reports Q3 Loss, Tops Revenue Estimates
by Zacks Equity Research
Beauty Health (SKIN) delivered earnings and revenue surprises of -12.50% and +2.84%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
SKINNegative Net Change SNDAPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank